Share this page

 ZIVIZO — 2396927

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2396927

Type(s)

Standard Characters

Category

Trademark

CIPO Status

APPROVED

TM5 status

LIVE/APPLICATION/ Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Filed

2025-05-07

Applicant

SAMSUNG BIOEPIS CO., LTD.
76, Songdogyoyuk-ro
Yeonsu-gu, Incheon,
REPUBLIC OF KOREA

Agent

GOWLING WLG (CANADA) LLP
SUITE 1600
1 FIRST CANADIAN PLACE
100 KING STREET WEST
TORONTO
ONTARIO M5X1G5

Documents

View documents

Index headings

  • ZIVIZO

Goods (Nice class & Statement)

5
(1) Pharmaceuticals for the treatment of eye diseases, disorders, and conditions; medicines for human purposes for the treatment of retinal diseases, eye diseases and conditions, ocular disorders and diseases, and for ocular or intraocular surgery; pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; ophthalmic preparations; pharmaceutical preparations for treating diabetes; human vaccine preparations; biological tissue cultures for medical purposes; pharmaceutical preparations for the treatment of inflammatory eye diseases; antidiabetic preparations; pharmaceutical preparations for treating metabolic syndrome; pharmaceutical preparations for the treatment of eye diseases caused by diseases of the metabolic system; pharmaceutical preparations for the prevention of ocular disorders; pharmaceutical preparations for the prevention of ocular diseases; cardiovascular pharmaceutical preparations for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; dietary supplements for general health and well being

Action History

Actions
Action Action date Due date Comments
Filed 2025-05-07
Created 2025-05-07
Formalized 2025-05-07
Pre-Assessment Letter Sent 2025-05-22 Retired Goods or Services
Search Recorded 2026-02-03
Examiner's First Report 2026-02-03 2026-08-03
Approved 2026-10-22 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2026-10-22 APPROVED BY PROGRAM EX200M1
Report a problem on this page
Date modified: